Published in Medical Device Law Weekly, May 1st, 2005
A portion of the shares will be issued and sold by Adams Laboratories, and a portion will be sold by certain stockholders of Adams Laboratories.
Merrill Lynch & Co. and Morgan Stanley are acting as joint book-running managers for the offering. In addition, Deutsche Bank Securities and RBC Capital Markets are acting as comanagers for the offering.
A registration statement relating to these securities...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.